Neutrophil to high-density lipoprotein cholesterol ratio as the risk mark in patients with type 2 diabetes combined with acute coronary syndrome: a cross-sectional study

Abstract Chronic inflammation and dyslipidemia are important risk factors in developing atherosclerotic cardiovascular disease, such as coronary heart disease. Acute coronary syndrome (ACS) is one of the most dangerous syndromes in coronary heart disease. Type 2 diabetes mellitus (T2DM) is considere...

Full description

Bibliographic Details
Main Authors: Hao Ren, Botao Zhu, Zhenyu Zhao, Yuan Li, Guiyuan Deng, Zewei Wang, Boyan Ma, Yuxin Feng, Zaiqiu Zhang, Xiaoxuan Zhao, Md Sayed Ali Sheikh, Ke Xia
Format: Article
Language:English
Published: Nature Portfolio 2023-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-35050-6
_version_ 1797822885433180160
author Hao Ren
Botao Zhu
Zhenyu Zhao
Yuan Li
Guiyuan Deng
Zewei Wang
Boyan Ma
Yuxin Feng
Zaiqiu Zhang
Xiaoxuan Zhao
Md Sayed Ali Sheikh
Ke Xia
author_facet Hao Ren
Botao Zhu
Zhenyu Zhao
Yuan Li
Guiyuan Deng
Zewei Wang
Boyan Ma
Yuxin Feng
Zaiqiu Zhang
Xiaoxuan Zhao
Md Sayed Ali Sheikh
Ke Xia
author_sort Hao Ren
collection DOAJ
description Abstract Chronic inflammation and dyslipidemia are important risk factors in developing atherosclerotic cardiovascular disease, such as coronary heart disease. Acute coronary syndrome (ACS) is one of the most dangerous syndromes in coronary heart disease. Type 2 diabetes mellitus (T2DM) is considered equal to coronary heart disease owing to the high cardiac risk induced by chronic inflammation and dyslipidemia. The neutrophil to high-density lipoprotein cholesterol ratio (NHR) is a novel and straightforward marker that reflects inflammation and lipid metabolic disorder. However, few studies have been on the role of NHR in assessing the risk of ACS in T2DM patients. Here we analyzed NHR level in ACS patients with T2DM, exploring its predictive and diagnostic values. 211 hospitalized ACS patients with T2DM were recruited as the case group, and 168 hospitalized T2DM patients as the control group (all patients collected from 6/2020 to 12/2021 in Xiangya Hospital). Biochemical test results and echocardiograms, as well as demographic information such as age, BMI, diabetes mellitus, smoking, drinking, and history of hypertension, were recorded. Frequencies, percentages, means, and standard deviations were used to describe the data. The shapiro–Wilk test was used to assess the normality of the data. Normally distributed data were compared using the independent sample T-test, and non-normally distributed data were compared using Mann–Whitney U test. Correlation analysis was performed using the Spearman rank correlation test, and receiver operating characteristic (ROC) curve analysis and multivariable logistic regression analysis were performed by SPSS version 24.0 (SPSS Inc) and GraphPad Prism 9.0 (GraphPad Software Inc). p < 0.05 was considered significant. In the study population, NHR was higher in patients with T2DM combined with ACS than in T2DM patients without ACS (p < 0.001). After adjusting for BMI, alcohol consumption, and history of hypertension, multifactorial logistic regression analysis revealed that NHR is a risk factor for T2DM patients combined with ACS (OR 1.221, p = 0.0126). Correlation analysis on all ACS patients with T2DM showed that NHR level was positively correlated with cTnI (r = 0.437, p < 0.001), CK (r = 0.258, p = 0.001), CK-Mb (r = 0.447, p < 0.001), LDH (r = 384, p < 0.001), Mb (r = 0.320, p < 0.001), LA (r = 0.168, p = 0.042) and LV levels (r = 0.283, p = 0.001). And meanwhile, NHR level was negatively correlated with EF (r = − 0.327, p < 0.001) and FS levels (r = − 0.347, p < 0.001). ROC curve analysis showed that NHR ≧ 4.32 had a sensitivity of 65.45% and a specificity of 66.19% for predicting ACS in T2DM patients [area under the curve (AUC) = 0.722, p < 0.001]. Furthermore, in all ACS patients with T2DM, the diagnostic power of NHR was stronger in ST-segment elevated ACS patients (STE-ACS) than that in non-ST-segment elevated ACS patients (NSTE-ACS) (p < 0.001). With its convenience and effective character, NHR could be a potential and new marker for predicting the presence, progression, and severity of ACS in T2DM population.
first_indexed 2024-03-13T10:15:54Z
format Article
id doaj.art-904e33648424493aa977c4526d0ebb5d
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-13T10:15:54Z
publishDate 2023-05-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-904e33648424493aa977c4526d0ebb5d2023-05-21T11:13:48ZengNature PortfolioScientific Reports2045-23222023-05-011311810.1038/s41598-023-35050-6Neutrophil to high-density lipoprotein cholesterol ratio as the risk mark in patients with type 2 diabetes combined with acute coronary syndrome: a cross-sectional studyHao Ren0Botao Zhu1Zhenyu Zhao2Yuan Li3Guiyuan Deng4Zewei Wang5Boyan Ma6Yuxin Feng7Zaiqiu Zhang8Xiaoxuan Zhao9Md Sayed Ali Sheikh10Ke Xia11Department of Cardiology, Xiangya Hospital, Central South UniversityDepartment of Cardiology, Xiangya Hospital, Central South UniversityThe Institute of Clinical Pharmacology, Xiangya Hospital, Central South UniversityDepartment of Cardiology, Xiangya Hospital, Central South UniversityDepartment of Cardiology, Xiangya Hospital, Central South UniversityDepartment of Cardiology, Xiangya Hospital, Central South UniversityDepartment of Cardiology, Xiangya Hospital, Central South UniversityDepartment of Cardiology, Xiangya Hospital, Central South UniversityDepartment of Cardiology, Xiangya Hospital, Central South UniversityDepartment of Cardiology, Xiangya Hospital, Central South UniversityInternal Medicine Department, Cardiology, College of Medicine, Jouf UniversityDepartment of Cardiology, Xiangya Hospital, Central South UniversityAbstract Chronic inflammation and dyslipidemia are important risk factors in developing atherosclerotic cardiovascular disease, such as coronary heart disease. Acute coronary syndrome (ACS) is one of the most dangerous syndromes in coronary heart disease. Type 2 diabetes mellitus (T2DM) is considered equal to coronary heart disease owing to the high cardiac risk induced by chronic inflammation and dyslipidemia. The neutrophil to high-density lipoprotein cholesterol ratio (NHR) is a novel and straightforward marker that reflects inflammation and lipid metabolic disorder. However, few studies have been on the role of NHR in assessing the risk of ACS in T2DM patients. Here we analyzed NHR level in ACS patients with T2DM, exploring its predictive and diagnostic values. 211 hospitalized ACS patients with T2DM were recruited as the case group, and 168 hospitalized T2DM patients as the control group (all patients collected from 6/2020 to 12/2021 in Xiangya Hospital). Biochemical test results and echocardiograms, as well as demographic information such as age, BMI, diabetes mellitus, smoking, drinking, and history of hypertension, were recorded. Frequencies, percentages, means, and standard deviations were used to describe the data. The shapiro–Wilk test was used to assess the normality of the data. Normally distributed data were compared using the independent sample T-test, and non-normally distributed data were compared using Mann–Whitney U test. Correlation analysis was performed using the Spearman rank correlation test, and receiver operating characteristic (ROC) curve analysis and multivariable logistic regression analysis were performed by SPSS version 24.0 (SPSS Inc) and GraphPad Prism 9.0 (GraphPad Software Inc). p < 0.05 was considered significant. In the study population, NHR was higher in patients with T2DM combined with ACS than in T2DM patients without ACS (p < 0.001). After adjusting for BMI, alcohol consumption, and history of hypertension, multifactorial logistic regression analysis revealed that NHR is a risk factor for T2DM patients combined with ACS (OR 1.221, p = 0.0126). Correlation analysis on all ACS patients with T2DM showed that NHR level was positively correlated with cTnI (r = 0.437, p < 0.001), CK (r = 0.258, p = 0.001), CK-Mb (r = 0.447, p < 0.001), LDH (r = 384, p < 0.001), Mb (r = 0.320, p < 0.001), LA (r = 0.168, p = 0.042) and LV levels (r = 0.283, p = 0.001). And meanwhile, NHR level was negatively correlated with EF (r = − 0.327, p < 0.001) and FS levels (r = − 0.347, p < 0.001). ROC curve analysis showed that NHR ≧ 4.32 had a sensitivity of 65.45% and a specificity of 66.19% for predicting ACS in T2DM patients [area under the curve (AUC) = 0.722, p < 0.001]. Furthermore, in all ACS patients with T2DM, the diagnostic power of NHR was stronger in ST-segment elevated ACS patients (STE-ACS) than that in non-ST-segment elevated ACS patients (NSTE-ACS) (p < 0.001). With its convenience and effective character, NHR could be a potential and new marker for predicting the presence, progression, and severity of ACS in T2DM population.https://doi.org/10.1038/s41598-023-35050-6
spellingShingle Hao Ren
Botao Zhu
Zhenyu Zhao
Yuan Li
Guiyuan Deng
Zewei Wang
Boyan Ma
Yuxin Feng
Zaiqiu Zhang
Xiaoxuan Zhao
Md Sayed Ali Sheikh
Ke Xia
Neutrophil to high-density lipoprotein cholesterol ratio as the risk mark in patients with type 2 diabetes combined with acute coronary syndrome: a cross-sectional study
Scientific Reports
title Neutrophil to high-density lipoprotein cholesterol ratio as the risk mark in patients with type 2 diabetes combined with acute coronary syndrome: a cross-sectional study
title_full Neutrophil to high-density lipoprotein cholesterol ratio as the risk mark in patients with type 2 diabetes combined with acute coronary syndrome: a cross-sectional study
title_fullStr Neutrophil to high-density lipoprotein cholesterol ratio as the risk mark in patients with type 2 diabetes combined with acute coronary syndrome: a cross-sectional study
title_full_unstemmed Neutrophil to high-density lipoprotein cholesterol ratio as the risk mark in patients with type 2 diabetes combined with acute coronary syndrome: a cross-sectional study
title_short Neutrophil to high-density lipoprotein cholesterol ratio as the risk mark in patients with type 2 diabetes combined with acute coronary syndrome: a cross-sectional study
title_sort neutrophil to high density lipoprotein cholesterol ratio as the risk mark in patients with type 2 diabetes combined with acute coronary syndrome a cross sectional study
url https://doi.org/10.1038/s41598-023-35050-6
work_keys_str_mv AT haoren neutrophiltohighdensitylipoproteincholesterolratioastheriskmarkinpatientswithtype2diabetescombinedwithacutecoronarysyndromeacrosssectionalstudy
AT botaozhu neutrophiltohighdensitylipoproteincholesterolratioastheriskmarkinpatientswithtype2diabetescombinedwithacutecoronarysyndromeacrosssectionalstudy
AT zhenyuzhao neutrophiltohighdensitylipoproteincholesterolratioastheriskmarkinpatientswithtype2diabetescombinedwithacutecoronarysyndromeacrosssectionalstudy
AT yuanli neutrophiltohighdensitylipoproteincholesterolratioastheriskmarkinpatientswithtype2diabetescombinedwithacutecoronarysyndromeacrosssectionalstudy
AT guiyuandeng neutrophiltohighdensitylipoproteincholesterolratioastheriskmarkinpatientswithtype2diabetescombinedwithacutecoronarysyndromeacrosssectionalstudy
AT zeweiwang neutrophiltohighdensitylipoproteincholesterolratioastheriskmarkinpatientswithtype2diabetescombinedwithacutecoronarysyndromeacrosssectionalstudy
AT boyanma neutrophiltohighdensitylipoproteincholesterolratioastheriskmarkinpatientswithtype2diabetescombinedwithacutecoronarysyndromeacrosssectionalstudy
AT yuxinfeng neutrophiltohighdensitylipoproteincholesterolratioastheriskmarkinpatientswithtype2diabetescombinedwithacutecoronarysyndromeacrosssectionalstudy
AT zaiqiuzhang neutrophiltohighdensitylipoproteincholesterolratioastheriskmarkinpatientswithtype2diabetescombinedwithacutecoronarysyndromeacrosssectionalstudy
AT xiaoxuanzhao neutrophiltohighdensitylipoproteincholesterolratioastheriskmarkinpatientswithtype2diabetescombinedwithacutecoronarysyndromeacrosssectionalstudy
AT mdsayedalisheikh neutrophiltohighdensitylipoproteincholesterolratioastheriskmarkinpatientswithtype2diabetescombinedwithacutecoronarysyndromeacrosssectionalstudy
AT kexia neutrophiltohighdensitylipoproteincholesterolratioastheriskmarkinpatientswithtype2diabetescombinedwithacutecoronarysyndromeacrosssectionalstudy